Evaluation of disability in patients exposed to fluoroquinolones.
Marsha A WilcoxAngelina Villasis-KeeverAnthony G SenaChristopher KnollDaniel FifePublished in: BMC pharmacology & toxicology (2020)
Comparative assessments are difficult to conduct in spontaneous reports. This examination of disability associated with adverse events in different system organ classes showed no difference between fluoroquinolones and azithromycin or sulfamethoxazole in administrative data.